A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder	Active, not recruiting	Phase 3	2026-06-12		NCT06297655

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	32

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Anhui Provincial Hospital	Hefei	China	7
Fuyang Hospital Affiliated to Anhui Medical University	Fuyang	China	1
Hematology Hospital of Chinese Academy of Medical Sciences	Tianjin	China	1
Henan Tumor Hospital	Zhengzhou	China	1
Jiangxi Provincial People's Hospital	Nanchang	China	19
Nanfang Hospital, Southern Medical University	Guangzhou	China	83
Nanjing Drug Tower Hospital	Nanjing	China	1
The First Affiliated Hospital of Guangxi Medical University	Nanning	China	66
The First Hospital of Lanzhou University	Lanzhou	China	3
The Second Affiliated Hospital of Chongqing Medical University	Chongqing	China	17
The Second Affiliated Hospital of Kunming Medical University	Kunming	China	2
Xiangya Hospital Central South University	Changsha	China	35